These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 16434452

  • 21. Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta.
    Land C, Rauch F, Glorieux FH.
    J Bone Miner Res; 2006 Mar; 21(3):374-9. PubMed ID: 16491284
    [Abstract] [Full Text] [Related]

  • 22. Large osteoclasts in pediatric osteogenesis imperfecta patients receiving intravenous pamidronate.
    Cheung MS, Glorieux FH, Rauch F.
    J Bone Miner Res; 2009 Apr; 24(4):669-74. PubMed ID: 19063679
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.
    Lindahl K, Kindmark A, Rubin CJ, Malmgren B, Grigelioniene G, Söderhäll S, Ljunggren Ö, Åström E.
    Bone; 2016 Jun; 87():11-8. PubMed ID: 26957348
    [Abstract] [Full Text] [Related]

  • 25. Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study.
    Ward LM, Rauch F, Whyte MP, D'Astous J, Gates PE, Grogan D, Lester EL, McCall RE, Pressly TA, Sanders JO, Smith PA, Steiner RD, Sullivan E, Tyerman G, Smith-Wright DL, Verbruggen N, Heyden N, Lombardi A, Glorieux FH.
    J Clin Endocrinol Metab; 2011 Feb; 96(2):355-64. PubMed ID: 21106710
    [Abstract] [Full Text] [Related]

  • 26. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K, Phillipi CA, Steiner RD, Basel D.
    Cochrane Database Syst Rev; 2016 Oct 19; 10(10):CD005088. PubMed ID: 27760454
    [Abstract] [Full Text] [Related]

  • 27. Intravenous pamidronate treatment in children with moderate-to-severe osteogenesis imperfecta started under three years of age.
    Alcausin MB, Briody J, Pacey V, Ault J, McQuade M, Bridge C, Engelbert RH, Sillence DO, Munns CF.
    Horm Res Paediatr; 2013 Oct 19; 79(6):333-40. PubMed ID: 23735642
    [Abstract] [Full Text] [Related]

  • 28. Intravenous pamidronate treatment in children with moderate to severe osteogenesis imperfecta: assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy.
    Arikoski P, Silverwood B, Tillmann V, Bishop NJ.
    Bone; 2004 Mar 19; 34(3):539-46. PubMed ID: 15003801
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy.
    Rauch F, Plotkin H, Zeitlin L, Glorieux FH.
    J Bone Miner Res; 2003 Apr 19; 18(4):610-4. PubMed ID: 12674321
    [Abstract] [Full Text] [Related]

  • 31. Bone mineral density and fracture rate in response to intravenous and oral bisphosphonates in adult osteogenesis imperfecta.
    Shapiro JR, Thompson CB, Wu Y, Nunes M, Gillen C.
    Calcif Tissue Int; 2010 Aug 19; 87(2):120-9. PubMed ID: 20544187
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Osteogenesis imperfecta: anthropometric, skeletal and mineral metabolic effects of long-term intravenous pamidronate therapy.
    Vallo A, Rodriguez-Leyva F, Rodríguez Soriano J.
    Acta Paediatr; 2006 Mar 19; 95(3):332-9. PubMed ID: 16497645
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pamidronate treatment of less severe forms of osteogenesis imperfecta in children.
    Zacharin M, Kanumakala S.
    J Pediatr Endocrinol Metab; 2004 Nov 19; 17(11):1511-7. PubMed ID: 15570988
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.